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The authors report the case of a 19-year-old male patient with Crohn’s disease treated with
inﬂiximab and azathioprine, with sustained clinical remission; in the course of the evolution,
this  patient showed a vascular malformation in his rectum, with daily massive bleeding, in
need of several blood transfusions and ﬁnally with an indication for surgical treatment. Data
from the literature on the association of the injury at issue and CD, as well as the drugs used
by  the patient, are evaluated. The literature lacks information linking this malformation with
CD  or with the drugs used.
©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Hemorragia  digestiva  baixa  por  malformac¸ão vascular  em  paciente  com
doenc¸a  de  Crohn:  relato  de  caso  e  revisão  da  literatura
Palavras-chave:
Doenc¸a de Crohn
Complicac¸ões
Mal-formac¸ão vascular
r  e  s  u  m  o
Os autores relatam o caso de um paciente masculino de 19 anos que apresenta doenc¸a
de Crohn em tratamento com Inﬂiximabe e Azatioprina com remissão clínica sustentada, o
qual  apresenta ao longo da evoluc¸ão uma mal-formac¸ão vascular no reto, com sangramento
diário volumoso, necessitando de diversas transfusões sanguíneas e ﬁnalmente a indicac¸ão
de  tratamento cirúrgico. São avaliados os dados da literatura quanto à associac¸ão da lesão
apresentada e a DC bem como com os medicamentos em uso pelo paciente. Não há naliteratura pesquisada nenhuma informac¸ão que associe a mal-formac¸ão com a DC nemtampouco os medicamen
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Fig. 2 – Intermediate portion of the rectum with vascularj coloproctol (rio j). 
ntroduction
rohn’s disease (CD) has become increasingly common in our
nvironment, and in a very special way this condition affects
oung individuals. Depending on the manner in which DC
anifests itself, the disease can cause a departure of the
atient from his/her daily activities, which represents great
osses, both personally and socially.
Among the various complications that the disease may
ause, bowel bleeding is not the most frequent and, when it
ccurs, this complication tends to be benign, provided that an
djustment of the treatment of the inﬂammatory process is
arried out.
In this case report, we describe an unusual situation, that
f a young man  with DC in remission who came to us with
aily rectal bleeding, an event at ﬁrst understood as a possible
ecurrence of the disease. But the investigation found that the
ause of the bleeding was a condition of vascular origin in the
ectum. The aim of this study was to determine whether there
as some relationship of this vascular lesion with DC or with
he drugs in use, or whether it was just a coincidence.
ase  report
 male patient, 19 years old, with a colonoscopy diagno-
is of CD established seven years ago, showing chronic,
onspeciﬁc ileitis and colitis; at that time, a scheme with pred-
isone + inﬂiximab (growth deﬁcit) was instituted. The patient
howed clinical improvement; thus, prednisone was discon-
inued and, after six months, a new colonoscopy showed that
he disease was in remission. The patient continued the use
f inﬂiximab. Four years ago, the patient had a relapse, when
zathioprine was prescribed, and an adjustment of inﬂiximab
ose was carried out, again with a good response and com-
lete remission. About a year ago, the patient came to us
ith a new low bleeding picture; the colonoscopy revealed
 rectum with an extensive purple/blue subepithelial area
ig. 1 – Distal portion of the rectum without vascular lesion.lesion.
suggestive of ischemia or hemorrhage (Figs. 1–3) with no evi-
dence of an active inﬂammatory disease. Then, the patient
was submitted to a proctology examination under sedation,
and dilated hemorrhoidal vessels were found in the entire
anal circumference, with a distal rectum without change. A
CT scan revealed an abdomen with mild thickening and hypo-
tonia of iliac loops + thickening and hypotonia of the distal
sigmoid colon and rectum. A bowel arteriogram demonstrated
an arteriovenous malformation in the upper and lower mesen-
teric arteries (Figs. 4–6) without signs of ischemia. Taking
into account that the bleeding persisted for several months,
requiring eight blood transfusions, it was decided to perform
a surgery. The patient underwent a proctectomy with coloanal
anastomosis and a protective ileostomy, with good evolution.
The histopathologic examination conﬁrmed that the case was
Fig. 3 – Intermediate portion of the rectum with vascular
lesion.
246  j coloproctol (rio j). 2 0 1 6;3  6(4):244–247Fig. 4 – MFV  in upper mesenteric artery.
one of a vascular malformation without disease activity in the
resected material.
Discussion
The occurrence of lower gastrointestinal bleeding (LGB) in
patients with DC is an infrequent complication. Li et al.1 evalu-
ated 1374 patients with active disease; 5.31% showed LGB. The
authors noted that the recent use of azathioprine and active
disease in the left colon were the main factors related to this
outcome. The patient here reported had no active disease and
was using azathioprine for more  than three years.
It is well known that the majority of CD patients require
surgical treatment throughout their life, but bowel resections
are almost always practiced for the treatment of active dis-
ease. Peng et al.2 evaluated the main indications for surgery
Fig. 5 – MFV  in upper mesenteric artery.Fig. 6 – MFV  in intermediate portion of the rectum.
in patients with CD and found that obstruction or stenosis
ranked ﬁrst (23.84%), followed by therapeutic failure (14.80%).
Intestinal bleeding was only the eighth most frequent indica-
tion, with 4.79% of cases; at this point, it should be noted that
notwithstanding this ﬁnding, this complication was related
to disease activity, not to associated disorders, e.g., vascular
malformation (as that observed in the present report).
Some authors have reported cases of vascular malforma-
tion in the rectum with frequent bleeding (as in the case
here presented), and most of these patients also require
surgical resection. However, the medical literature surveyed
lacks studies in which this fact has occurred in individuals
with CD.3
Jabłon´ska et al.4 reported a case of vascular malformation
that occurred in a patient with CD, but it was a case of an
injury on the path of an enterocutaneous ﬁstula. The authors
emphasized the scarcity of studies with similar cases, which
leads us to believe that probably there is no relationship of
DC with a vascular malformation. Thus, the question to be
answered is whether the treatment used in this case could
be in some way associated with vascular malformation, since
this complication arose after the use of this therapy.
Sokumbi et al.5 reviewed cases of vasculitis in CD patients
on anti-TNF and observed a prevalence of skin lesions, but
these authors also observed systemic and renal lesions, some
of them coursing with bleeding episodes. Several other com-
plications have been reported with the use of anti-tumor
necrosis factor (TNF) alpha antibodies, including interstitial
lung disease, skin lesions, opportunistic infections, etc.; how-
ever, no bowel vascular lesion was identiﬁed.6
Azathioprine has also been extensively studied with
respect to its complications and adverse effects in patients
with inﬂammatory bowel disease. Most studies suggest the
possibility of infectious complications, and the development
of a lymphoma is the most dreaded of all complications,
especially when associated with the use of anti-TNF. But the
occurrence of vascular malformation has not been linked to
this treatment.7
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Thus, it can be concluded that neither DC nor its treat-
ent appears to be related to the onset of bowel vascular
alformation; however, considering the lack of articles
ddressing this issue, our report plays a big role, thanks
o the documentation of the observed complication, as
n eventual contribution to other publications that may
rise.
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